News
Curium Partners with Oncidium Foundation to Support Access to Radioligand Therapy
11th May 2026
Our continuous innovation in this field exemplifies our dedication to enhancing the accuracy of NET detection and diagnosis. Together, we can take on NETs from diagnosis to beyond. We partner with patient advocacy groups that provide a voice for the NET community by spreading awareness, supporting patients and caregivers, and funding research.
Discover how these organizations are committed to supporting the NET community.
NET Cancer Awareness is a global initiative dedicated to raising awareness of neuroendocrine tumours (NETs), a rare and often misunderstood group of cancers that can develop throughout the body. The campaign aims to improve understanding, support earlier diagnosis, advance research, and give a stronger voice to patients, caregivers, and healthcare professionals affected by NETs worldwide.
The Neuroendocrine Cancer Foundation (NCF) is a patient advocacy organisation dedicated to supporting individuals and families affected by neuroendocrine cancer through education, awareness, and community connection. Through expert-led resources, patient programmes, support networks, and advocacy initiatives, NCF helps empower patients and improve understanding of neuroendocrine tumours (NETs) worldwide.
The International Neuroendocrine Cancer Alliance (INCA) is a global patient advocacy organisation dedicated to improving awareness, education, diagnosis, treatment, and support for people affected by neuroendocrine tumours (NETs). Through international collaboration with patient groups, healthcare professionals, and researchers, INCA works to strengthen the global NET community and help improve outcomes for patients and caregivers worldwide.
The Healing NET Foundation is a patient-led organisation dedicated to supporting individuals and families affected by neuroendocrine tumours (NETs) through education, advocacy, and community connection. Founded by NET patients and caregivers, the organisation focuses on raising awareness, empowering patients with reliable information, and fostering hope and support throughout the NET journey.
Cancer Advocacy Group of Louisiana (CAGLA) is a patient advocacy organisation dedicated to supporting individuals and families affected by cancer across Louisiana through education, awareness, advocacy, and community outreach. The organisation works to improve access to resources, strengthen patient support networks, and help ensure that patients and caregivers feel informed, empowered, and connected throughout their cancer journey.
The Neuroendocrine Tumor Research Foundation (NETRF) is a non-profit organisation dedicated to funding innovative research and advancing scientific understanding of neuroendocrine cancers. Through research grants, education, and patient resources, NETRF works to accelerate breakthroughs in diagnosis and treatment while improving outcomes for people affected by neuroendocrine tumours (NETs).
At Curium, our purpose is clear: to drive innovation in nuclear medicine that improves patients’ lives. As a global leader in radiopharmaceuticals, we are in a unique position to shape the future of the field. Everything we do is centered on people: patients, healthcare professionals, our employees, and the communities we serve. Guided by this commitment, we are forging a new path forward for millions of people worldwide.
News
11th May 2026
News
17th March 2026
News
17th November 2025